Home/Filings/4/0001628280-25-000235
4//SEC Filing

Lecault Veronique 4

Accession 0001628280-25-000235

CIK 0001703057other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 3:40 PM ET

Size

5.6 KB

Accession

0001628280-25-000235

Insider Transaction Report

Form 4
Period: 2025-01-01
Lecault Veronique
DirectorChief Technology Officer
Transactions
  • Award

    Share option (right to buy)

    2025-01-01+832,0334,661,804 total
    Exercise: $2.93Exp: 2035-01-01Common Shares (832,033 underlying)
Footnotes (1)
  • [F1]The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834418

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:40 PM ET
Size
5.6 KB